RAC 3.79% $1.53 race oncology ltd

Ann: Appendix 4D & Half-Year Financial Statements, page-40

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 502 Posts.
    lightbulb Created with Sketch. 457
    @Davisite the directors report suggests Race has received strong clinical interest from a range of Australian oncologists interested in participating in the phase 1a/b trial.

    Wondering whether additional interest is still required and how a party would best contact Race to register its interest?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.